1
One Sample
A simple at-home finger-prick collected over 5 days. No clinic visits, no fasting, friction-free scaling.
Investor Relations
Building the infrastructure for preventive medicine.
We turn a single finger-prick into a continuously learning virtual twin. A dual-engine model: TwinMe monetizes non-medical wellness today, while BioTwin builds regulated clinical AI for cancer screening decision assistance and future disease detection pathways.
Clinical availability: UAE only, through participating physicians in authorized settings. BioTwin is not authorized as a medical device in Canada or the United States. TwinMe is the non-medical wellness experience powered by BioTwin.
- UAE physician-led clinical use
- Microsoft for Startups
- $5M raised
Our Core Asset
Your Bio-Signature. Results organized by program.
Your Bio-Signature. Results organized by program.
Human virtual twin.
Standard lab panels quantify selected analytes. Using mass spectrometry, BioTwin maps biomarker-derived metabolic signals from a Bio-Signature sample to create a high-dimensional dataset for its proprietary AI. Program results are then organized into Bio-Signatures. This is not equivalent to standard lab work.
2
High-dimensional signals
High-resolution mass spectrometry creates a high-dimensional metabolic signal dataset, not just a targeted checklist.
3
Program-level Bio-Signatures
Each program organizes its results into Bio-Signatures that group biomarkers related to the same health or well-being dimension.
4
Virtual Twin
A living mathematical model that learns retroactively. When our research team adds a new analysis, the twin updates without a new kit.
Go-to-market strategy
Consumer today.
Consumer today.
Clinical tomorrow.
The data required to train clinical AI for complex diseases is vast and expensive to acquire. BioTwin solves this cold-start problem through a self-funding data flywheel.
-
TwinMe (Consumer): We deliver immediate value through our commercial wellness programs (such as Longevity, Elite Optimization and Weight) generating immediate revenue.
-
BioTwin (Clinical): Where participants consent, de-identified data can contribute to BioTwin's research programs, including oncology.
N=1
Personalized
Medicine
Medicine
"Our goal is to detect minute biological deviations before they manifest as clinical symptoms, by mapping individual trajectories rather than population averages."
Scientific Pipeline
Active clinical traction.
Our virtual twin technology is being evaluated with participating physicians in a clinical study in the United Arab Emirates.
Clinical pilot, active
Abu Dhabi, UAE UAE clinical pilot
BioTwin's first clinical pilot delivers results today through partner physicians under the regulatory framework of the United Arab Emirates.
Scope: six cancers, with breast and colorectal cancer as the priority
Research in progress
Global Broader clinical pipeline
Beyond the UAE pilot, BioTwin runs active research programs globally.
- Oncology: Lung, Pancreas, Prostate, Ovarian
- Neurology: Alzheimer's, Parkinson's, Depression, Epilepsy
- Cardiology: Heart failure, Hypertension
These are scientific projects, and TwinMe kit data contributes directly to them.
Join our mission
We are building the definitive biological dataset for preventive medicine. To access our data room, clinical results, or speak with leadership, reach out today.
Contact Investor Relations